Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C2orf15 (chromosome 2 open reading frame 15) encodes a hypothetical protein of unknown function in humans[3][4][7]. In silico annotation predicts DNA and RNA binding properties, with a possible role in the regulation of transcription[2][5]. No validated molecular family classification (such as receptor, enzyme, or transporter) has been assigned to this gene. It does not appear in major databases as a drug target, disease biomarker, or therapeutic receptor, and currently remains uncharacterized and with very limited experimental data. Early computational analysis places C2orf15 among "hypothetical genes involved in information storage and processing," but without functional confirmation in human tissues[2][5].\n\nThere may be weak computational evidence suggesting a role in DNA or RNA binding and transcriptional regulation, but this remains only a prediction sourced from domain analysis and gene ontology algorithms[2][5]. No disease associations or direct evidence for involvement in human health or pathophysiology have been validated.
None known (there are no drugs or targeted therapies reported)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 2 open reading frame 15 (C2orf15).